Cite
HARVARD Citation
Puing, A. et al. (2022). Severe Acute Respiratory Syndrome Coronavirus 2–Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience. Journal of infectious diseases. pp. 352-354. [Online].